1 Results

Sort By: Published Date Updated Date Title ID Descending Ascending

Utilization of Human Recombinant Tinagl1 Protein in Inhibiting Triple-negative Breast Cancer Progression and Metastasis Utilization of human recombinant Tinagl1 protein in inhibiting triple-negative-breast cancer progression and metastasis Princeton Docket # 19-3526Researchers in Princeton University’s Department of Molecular Biology have developed the human recombinant protein Tubulointerstitial nephritis antigen like-1 (Tinagl1) as a promising treatment for triple-negative... Published: 9/27/2024   |   Inventor(s): Yibin Kang, Minhong Shen Keywords(s):   Category(s): Biotechnology/Pharmaceuticals